Peptides are not uniformly safe or dangerous. The meaningful question is whether a specific product has credible human evidence, reliable manufacturing, appropriate oversight, and risks that are understood for its intended use.
503A and 503B identify different U.S. drug-compounding frameworks—not peptide quality grades. Learn what each label establishes and what it cannot prove.
Glucagon-like peptide usually means GLP-1, a natural gut hormone involved in post-meal insulin, glucagon, and digestive signaling. Here is what the term means and how it differs from GLP-1 medicines.
Thymosin beta-4 and TB-500 are related but distinct peptides. Here is what human studies, FDA materials, and anti-doping rules actually establish.
Peptides are chains of amino acids, but that simple definition covers molecules with very different roles. Here is how peptide structure, processing, receptors, digestion, and medical evidence fit together.
Peptide safety cannot be reduced to a class-wide yes or no. Here is how to assess the evidence for approved, compounded, investigational, and research-use-only products.
